Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Recruiting 3Unknown 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 9OTHER 6NIH 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Lymphoid 3Dermatologic 1CNS 1

Conditions

Myasthenia Gravis 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Glioblastoma 1Arthritis, Rheumatoid 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Interventional × tofacitinib × Clear all
NCT06698822 2026-04-14

A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA

M.D. Anderson Cancer Center

Phase 2 Recruiting
20 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT05326464 2025-12-15

Tofacitinib in Recurrent GBM Patients

University of Texas Southwestern Medical Center

Phase 3 Active not recruiting
17 enrolled
CNS

Glioblastoma

NCT04431895 2025-09-16

Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study

Huashan Hospital

Phase EARLY_PHASE1 Completed
19 enrolled

Myasthenia Gravis

NCT03976245 2024-11-29

Advanced Therapeutics in Rheumatoid Arthritis (RA)

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 4 Recruiting
144 enrolled

Arthritis, Rheumatoid

NCT05348213 2024-10-23

R-ICE+X

Ruijin Hospital

Phase 2 Recruiting
76 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT03598959 2018-07-26

Tofacitinib Combined With Chidamide in R/R ENKTCL

Sichuan University

Phase 2 Unknown
20 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡